Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
Condition(s):Solid Tumor, AdultLast Updated:October 9, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Solid Tumor, AdultLast Updated:October 9, 2018Withdrawn
Condition(s):Small Cell Lung Cancer Limited StageLast Updated:June 5, 2023Recruiting
Condition(s):Metastatic Breast Cancer; Bevacizumab-alone Maintenance Treatment ProgressionLast Updated:June 19, 2020Completed
Condition(s):Non-small Cell Lung Cancer (NSCLC)Last Updated:November 7, 2023Completed
Condition(s):Extensive-stage Small Cell Lung CancerLast Updated:July 17, 2023Recruiting
Condition(s):Bladder CancerLast Updated:April 6, 2020Completed
Condition(s):Pancreatic AdenocarcinomaLast Updated:August 14, 2023Active, not recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:June 4, 2021Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:January 26, 2023Not yet recruiting
Condition(s):Pleura MesotheliomaLast Updated:March 15, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.